Use of immunosuppression and subsequent cancer incidence: cohort study.
Buchanich JM, Newcomb CW, Washington TL, Foster CS, Sobrin L, Thorne JE, Jabs DA, Suhler EB, Rosenbaum JT, Sen HN, Levy-Clarke GA, Nussenblatt RB, Bhatt NP, Lowder CY, Goldstein DA, Leiderman YI, Acharya NR, Holland GN, Read RW, Dunn JP, Dreger KA, Artornsombudh P, Begum HA, Fitzgerald TD, Kothari S, Payal AR, Daniel E, Gangaputra SS, Kaçmaz RO, Liesegang TL, Pujari SS, Khachatryan N, Maghsoudlou A, Suga HK, Pak CM, Helzlsouer KJ, Kempen JH.
Buchanich JM, et al. Among authors: payal ar.
BMJ Oncol. 2023 Aug 21;2(1):e000037. doi: 10.1136/bmjonc-2023-000037. eCollection 2023.
BMJ Oncol. 2023.
PMID: 39886503
Free PMC article.